GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
28 hedge funds and large institutions have $6.12M invested in Aevi Genomic Medicine Inc in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30.5K | |
| 2 | +$25.6K | |
| 3 | +$17.6K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$14.6K |
| 5 |
VF
Virtu Financial
New York
|
+$11.2K |
Top Sellers
| 1 | -$65.8K | |
| 2 | -$24K | |
| 3 | -$19K | |
| 4 |
Barclays
London,
United Kingdom
|
-$2 |